Tag: Dr Mimi Tang
Recruitment of Infants Begins for Phase 3 Trial of Cream to...
The trial needs 760 babies aged three weeks or younger whose parents or siblings suffer from either eczema, asthma or food allergies.
Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate
Study to provide evidence of longer lasting tolerance to peanut in a larger number of patients.
Study: Peanut Oral Immunotherapy Combined with Probiotic Achieves Lasting Results
Exciting news of lasting peanut tolerance four years after Probiotic + Peanut OIT treatment.
Peanut Allergy Treatment Receives Funding for Commercialization
"There’s a clear path to a marketable product here that could have tremendous impact globally."
News from Australia: Hospital Admissions for Anaphylaxis Jump
More children are developing food allergies of the type that are not typically grown out of.
